Nuvalent shares surge 39% after UK's GSK agrees to buy the drugmaker for $10.6 billion
CNBC 55 views
Topic timeline
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
Earliest in tracked window
Oldest report in the coverage window currently tracked for this topic.
STAT+: GSK says goodbye to leucovorin (again) statnews.com · Apr 10, 2026Latest update
Most recent tracked report from CNBC.
Nuvalent shares surge 39% after UK's GSK agrees to buy the drugmaker for $10.6 billion CNBC · Jun 9, 20263 reports in date order. Not enough independent coverage yet to show a development timeline.
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow